[HTML][HTML] Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment
The mammalian liver comprises heterogeneous cell types within its tissue microenvironment
that undergo pathophysiological reprogramming in disease states, such as non-alcoholic …
that undergo pathophysiological reprogramming in disease states, such as non-alcoholic …
[HTML][HTML] Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression
L Guo, P Zhang, Z Chen, H Xia, S Li… - The Journal of …, 2017 - Am Soc Clin Investig
Nonalcoholic steatohepatitis (NASH) is characterized by progressive liver injury,
inflammation, and fibrosis; however, the mechanisms that govern the transition from hepatic …
inflammation, and fibrosis; however, the mechanisms that govern the transition from hepatic …
Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC
The incidence of hepatocellular carcinoma (HCC) is rapidly rising largely because of
increased obesity leading to nonalcoholic steatohepatitis (NASH), a known HCC risk factor …
increased obesity leading to nonalcoholic steatohepatitis (NASH), a known HCC risk factor …
[HTML][HTML] Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease
Background & Aims Non-alcoholic fatty liver disease (NAFLD), the hepatic correlate of the
metabolic syndrome, is a major risk factor for hepatobiliary cancer (HBC). Although chronic …
metabolic syndrome, is a major risk factor for hepatobiliary cancer (HBC). Although chronic …
Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
JT Haas, L Vonghia, DA Mogilenko, AN Verrijken… - Nature …, 2019 - nature.com
Progression of fatty liver to non-alcoholic steatohepatitis (NASH) is a rapidly growing health
problem. The presence of inflammatory infiltrates in the liver and hepatocyte damage …
problem. The presence of inflammatory infiltrates in the liver and hepatocyte damage …
[PDF][PDF] T cells: friends and foes in NASH pathogenesis and hepatocarcinogenesis
P Ramadori, S Kam, M Heikenwalder - Hepatology, 2022 - Wiley Online Library
In association with the pandemic spreading of obesity and metabolic syndrome, the
prevalence of NAFLD‐related HCC is increasing almost exponentially. In recent years, many …
prevalence of NAFLD‐related HCC is increasing almost exponentially. In recent years, many …
[HTML][HTML] Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes
MJ Wolf, A Adili, K Piotrowitz, Z Abdullah, Y Boege… - Cancer cell, 2014 - cell.com
Hepatocellular carcinoma (HCC), the fastest rising cancer in the United States and
increasing in Europe, often occurs with nonalcoholic steatohepatitis (NASH). Mechanisms …
increasing in Europe, often occurs with nonalcoholic steatohepatitis (NASH). Mechanisms …
[HTML][HTML] An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular …
Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the
molecular mechanism remains obscure. Here, we show that an androgen receptor (AR) …
molecular mechanism remains obscure. Here, we show that an androgen receptor (AR) …
[HTML][HTML] ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development
H Nakagawa, A Umemura, K Taniguchi… - Cancer cell, 2014 - cell.com
Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of viral
hepatitis, insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH) …
hepatitis, insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH) …
Lessons from animal models of NASH
AM Diehl - Hepatology Research, 2005 - Elsevier
Studies of animals with obesity-related liver disease have taught us much about the
mechanisms that mediate this pathology. Our work with genetically obese, insulin-resistant …
mechanisms that mediate this pathology. Our work with genetically obese, insulin-resistant …